Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Investigating the safety and the activity of Rapamycin, administered before and during preoperative radiotherapy in patients with an operable colorectal carcinoma. The phase I dose escalation study will be performed in three steps (2, 4 and 6 mg). Patients entered in phase II will follow the same tolerable treatment regimen as patients in phase I study.
创建时间：
2006-09-15
